These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1965450)

  • 1. Tumor markers and cervical carcinoma.
    Taccone W; Belli M; Riccio M
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):63-6. PubMed ID: 1965450
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of squamous cell carcinoma antigen in the blood of patients with cancer of the uterine cervix].
    Tolino A; Di Serio C; Borruto Caracciolo G; Riccio S; Piragine L; Montemagno U
    Minerva Ginecol; 1989 Jul; 41(7):349-52. PubMed ID: 2608204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinoma.
    Meier W; Stieber P; Hasholzner U; Baumgartner L; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2959-62. PubMed ID: 9329575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The course of squamous cell cancer antigen in chemotherapy as a prognostic criterion in cervix cancer].
    Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
    Gynakol Rundsch; 1989; 29 Suppl 2():411-2. PubMed ID: 2613066
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tumor marker squamous cell carcinoma antigen].
    Lavie O; Neuman M; Zuckerman B; Hornreich G; Beller U
    Harefuah; 1998 Sep; 135(5-6):222-5. PubMed ID: 9885641
    [No Abstract]   [Full Text] [Related]  

  • 6. TAF test: a new tumor marker?
    Taccone W; Belli M; Riccio M
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):55-8. PubMed ID: 1965449
    [No Abstract]   [Full Text] [Related]  

  • 7. [New tumour markers useful in diagnostics and monitoring of cervical cancer].
    Bedkowska GE; Lawicki S; Szmitkowski M
    Przegl Lek; 2007; 64(12):1022-7. PubMed ID: 18595508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of various epithelial tumor markers and a stromal marker in the assessment of cervical carcinoma.
    Tomás C; Risteli J; Risteli L; Vuori J; Kauppila A
    Obstet Gynecol; 1991 Apr; 77(4):566-72. PubMed ID: 2002979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of a new tumor marker, CYFRA 21-1, in squamous cell carcinoma of the cervix, and comparison with squamous cell carcinoma antigen.
    Tsai SC; Kao CH; Wang SJ
    Neoplasma; 1996; 43(1):27-9. PubMed ID: 8843956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
    Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC).
    Hung YC; Shiau YC; Chang WC; Kao CH; Lin CC
    Neoplasma; 2002; 49(6):415-7. PubMed ID: 12584591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma.
    Bolger BS; Dabbas M; Lopes A; Monaghan JM
    Gynecol Oncol; 1997 May; 65(2):309-13. PubMed ID: 9159343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
    Kainz C; Sliutz G; Mustafa G; Bieglmayr C; Koelbl H; Reinthaller A; Gitsch G
    Gynecol Oncol; 1995 Mar; 56(3):402-5. PubMed ID: 7535720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Remarkably reduced tumor marker SCC levels by combined chemotherapy of paclitaxel and S-1 in two cases of advanced cervical cancer].
    Takagi K; Kougo H; Aoyagi Y; Yonehara T; Minobe S; Azuma M; Yamaguchi T
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):335-7. PubMed ID: 18281778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of marker antigens TPS, SCC and CEA in diagnosis, evaluation of histologic type and clinical disease progression in patients with cervical carcinoma].
    Zakrzewska I
    Pol Merkur Lekarski; 2001 Jan; 10(55):21-3. PubMed ID: 11320545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of Cyfra 21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancer.
    Gaarenstroom KN; Bonfrer JM; Korse CM; Kenter GG; Kenemans P
    Anticancer Res; 1997; 17(4B):2955-8. PubMed ID: 9329574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor markers in uterine cancers].
    Fukasawa I; Kousaka N; Kun Z; Inaba N
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):333-40. PubMed ID: 11865645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study.
    Niibe Y; Kazumoto T; Toita T; Yamazaki H; Higuchi K; Ii N; Suzuki K; Uno T; Tokumaru S; Takayama M; Sekiguchi K; Matsumoto Y; Michimoto K; Oguchi M; Hayakawa K
    Gynecol Oncol; 2006 Nov; 103(2):435-8. PubMed ID: 16677691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
    Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
    Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
    Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
    Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.